Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.

Neurology
S E BushnellR Medori

Abstract

There is a significant unmet need for serum biomarkers in relapsing-remitting multiple sclerosis (RRMS) that are predictive of therapeutic response to disease-modifying therapies. Following a recent Stanford study which reported that pretreatment levels of serum interleukin (IL)-17F could predict poor response to interferon-β (IFNβ) therapy, we sought to validate the finding using samples from a large clinical trial. The validation cohort included 54 good responders (GR) and 64 poor responders (PR) selected from 762 subjects with RRMS from the IM IFNβ-1a dose comparison study (Avonex study C94-805). Subjects were classified as GR and PR based on the number of relapses, Expanded Disability Status Scale score, and new and enlarging T2 lesions on MRI. Serum samples were assayed for IL-17F using a multiplexed Luminex assay and for IL-17F/F using an ELISA. Replicate aliquots from the Stanford study were also assayed to assure reproducibility of methods. Median pretreatment and post-treatment serum IL-17F levels were not statistically significantly different between GR and PR, and serum IL-7/IL-17F ratios were also not predictive of response status. Replicate aliquots from the Stanford study showed good correlation to their original ...Continue Reading

Citations

Dec 25, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Corey A McGraw, Fred D Lublin
Mar 20, 2013·CNS Drugs·Patricia K Coyle
Apr 18, 2014·PloS One·Maria D Chikina, Stuart C Sealfon
Dec 4, 2012·International Journal of Molecular Sciences·Katherine A BuzzardHelmut Butzkueven
Feb 13, 2013·Multiple Sclerosis International·Serafeim Katsavos, Maria Anagnostouli
Dec 11, 2013·Nature Reviews. Neurology·Paul M MatthewsMichael R Johnson
Jan 21, 2014·Annual Review of Immunology·Lawrence Steinman
Aug 2, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jerome J Graber, Suhayl Dhib-Jalbut
Aug 29, 2014·Molecular Diagnosis & Therapy·Violaine K Harris, Saud A Sadiq
Apr 1, 2014·Experimental Neurology·Christopher SieMeike Mitsdoerffer
Feb 4, 2014·Mayo Clinic Proceedings·Dean M Wingerchuk, Jonathan L Carter
Jan 5, 2016·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Masakazu NakamuraTakashi Yamamura
Feb 6, 2013·Clinical and Experimental Immunology·M F BustamanteM Comabella
Aug 26, 2014·Multiple Sclerosis International·Nikolaos DimisianosAthanasia Mouzaki
Dec 18, 2013·Lancet Neurology·Manuel Comabella, Xavier Montalban
Apr 13, 2013·Journal of the Neurological Sciences·Fred D Lublin
Dec 5, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Rodica BălaşaAdina Huţanu
Mar 14, 2013·Therapeutic Advances in Neurological Disorders·Charles Pierrot-Deseilligny, Jean-Claude Souberbielle
Jan 11, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Lawrence SteinmanJonathan B Rothbard
Jul 29, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Patrick VermerschMaria Trojano
Jul 31, 2013·Nature Reviews. Neurology·Maria Pia Sormani, Nicola De Stefano
Sep 14, 2019·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Miaomiao HouXinyi Li
Feb 20, 2016·Neurology. Neuroimmunology and Neuroinflammation·Harald HegenRobert C Axtell
Oct 27, 2017·Mass Spectrometry Reviews·Minnie JacobAnas M Abdel Rahman
Oct 14, 2017·Journal of Neurology·Raquel AlendaLuisa M Villar
Jan 10, 2018·Cold Spring Harbor Perspectives in Medicine·Simon Glatigny, Estelle Bettelli
Jun 26, 2012·Immunological Reviews·Robert C Axtell, Chander Raman
Jun 12, 2021·Frontiers in Immunology·Priyanka Devi-MarulkarFrédérique Michel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.